SERPINE1 and COVID-19: Data are presented that in patients with COVID-19 admitted to the ICU, the levels of plasminogen activator inhibitor-1 (PAI-1) and thrombin-activated fibrinolysis inhibitor (TAFI) are increased and a high ability to generate thrombin is observed, which was maintained even while taking heparin [444].